Cargando…

From GOLD 0 to Pre-COPD

Detalles Bibliográficos
Autores principales:	Han, MeiLan K., Agusti, Alvar, Celli, Bartolome R., Criner, Gerard J., Halpin, David M. G., Roche, Nicolas, Papi, Alberto, Stockley, Robert A., Wedzicha, Jadwiga, Vogelmeier, Claus F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Pulmonary Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885837/ https://www.ncbi.nlm.nih.gov/pubmed/33211970 http://dx.doi.org/10.1164/rccm.202008-3328PP

Ejemplares similares

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

Reply to Thomson, to Neder et al., and to Wouters
por: Han, MeiLan K., et al.
Publicado: (2021)

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
por: Agusti, Alvar, et al.
Publicado: (2023)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
por: Agustí, Alvar, et al.
Publicado: (2023)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

Natural history of COPD: gaps and opportunities
por: Agustí, Alvar, et al.
Publicado: (2017)

COPD: time to improve its taxonomy?
por: Celli, Bartolomé R., et al.
Publicado: (2018)

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study
por: Celli, Bartolome, et al.
Publicado: (2017)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Highlights and hot topics in the management of COPD: where are we heading?
por: Agustí, Alvar, et al.
Publicado: (2016)

Venous Admixture in COPD: Pathophysiology and Therapeutic Approaches
por: Cooper, Christopher B., et al.
Publicado: (2009)

Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
por: Celli, Bartolome R., et al.
Publicado: (2023)

Gold 2023: Highlights for primary care
por: Agustí, Alvar, et al.
Publicado: (2023)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022
por: Halpin, David M. G., et al.
Publicado: (2022)

Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
por: Vizza, Carmine Dario, et al.
Publicado: (2021)

Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
por: Brook, Robert D, et al.
Publicado: (2017)

Informe de la Barcelona-Boston Lung Conference 2021
por: Celli, Bartolomé, et al.
Publicado: (2021)

Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
por: Wedzicha, Jadwiga A., et al.
Publicado: (2016)

Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis
por: Gu, Yanhui, et al.
Publicado: (2021)

The Structural and Social Determinants of the Racial/Ethnic Disparities in the U.S. COVID-19 Pandemic. What’s Our Role?
por: Thakur, Neeta, et al.
Publicado: (2020)

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
por: Singh, Dave, et al.
Publicado: (2020)

Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2
por: Dhand, Rajiv, et al.
Publicado: (2020)

Latent Tuberculosis: Two Centuries of Confusion
por: Behr, Marcel A., et al.
Publicado: (2021)

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
por: Reddel, Helen K., et al.
Publicado: (2021)

Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection
por: Conway, Francesca M., et al.
Publicado: (2022)

Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
por: Cazzola, Mario, et al.
Publicado: (2023)

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial
por: Celli, Bartolome R, et al.
Publicado: (2019)

Variability of blood eosinophil count and prognosis of COPD exacerbations
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2021)

Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
por: Dotan, Yaniv, et al.
Publicado: (2020)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Safety and efficacy of catheter directed thrombolysis (CDT) in elderly with pulmonary embolism (PE)
por: Harrison, Eneida, et al.
Publicado: (2021)

Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial
por: Brill, Simon E, et al.
Publicado: (2015)

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
por: Halpin, David M.G., et al.
Publicado: (2021)

Hierarchical stratification of the factors related to exertional dyspnoea and exercise intolerance in male COPD patients
por: Chuang, Ming-Lung
Publicado: (2022)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database
por: Heresi, Gustavo A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2qc6jf0o2kjjhbirfr8vkgc763